YD Bio Ltd
YDES- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0002011674
In the last 90 days, YD Bio Ltd insiders filed 3 open-market purchases and 0 sales; 13 institutions reported holding it in 13F filings for Q2 2026, worth $639.6K in total; no superinvestor holds it.
Other share classesYDESW
13F holders, Q4 2025
Institutional positions in YD Bio Ltd as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 10
- 0 vs. Q3 2025
- Shares held
- 141.6K
- −33.9K (−19.3%) vs. Q3 2025
- Total value
- $1.73M
- −$1.69M (−49.5%) vs. Q3 2025
- New holders
- 4
- 1 more added
- Sold out
- 4
- 3 more reduced
Compare with Q3 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting YDES on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 13 | $639.6K |
| Q1 2026 | 8 | $1.23M |
| Q4 2025 | 10 | $1.73M |
| Q3 2025 | 10 | $3.42M |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2025
Shares, value and share of portfolio for each institution holding YD Bio Ltd; share changes are against Q3 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 58,363 | $711.4K | 0.00% | +5,292+10.0% | Added |
| Cerity Partners LLC | 32,406 | $395.0K | 0.00% | 00.0% | Unchanged |
| Cypress Capital Management LLC (WY) | 27,540 | $335.7K | 0.31% | −2,450−8.2% | Reduced |
| Citadel Advisors LLC | 11,549 | $140.8K | 0.00% | +11,549 | New |
| UBS Group AG | 7,192 | $87.7K | 0.00% | −3,124−30.3% | Reduced |
| Wolverine Asset Management LLC | 2,516 | $30.7K | 0.00% | +2,516 | New |
| Citigroup Inc | 1,709 | $20.8K | 0.00% | +1,709 | New |
| Morgan Stanley | 299 | $3.65K | 0.00% | −9,958−97.1% | Reduced |
| Bank of America Corp | 5 | $61 | 0.00% | +5 | New |
| FMR LLC | 1 | $12 | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 0 | $0 | 0.00% | −31,819−100.0% | Sold out |
| Clear Street Group Inc. | 0 | $0 | 0.00% | −7,500−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −90−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −58−100.0% | Sold out |